Riamilovir (Triazavirin) is a broad-spectrum antiviral drug candidate, which can be used for potential application against the Coronavirus 2019-nCoV.
[1] Shahab S, et al. Curr Mol Med. 2021;21(8):645-654.
Riamilovir (Triazavirin) is a broad-spectrum antiviral drug candidate, which can be used for potential application against the Coronavirus 2019-nCoV.
[1] Shahab S, et al. Curr Mol Med. 2021;21(8):645-654.